Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Thermo Fisher Scientific announced earnings per share of $6.54 on revenue of $10.7B. Analysts polled by Investing.com anticipated EPS of $4.89 on revenue of $8.75B.
Thermo Fisher Scientific shares are down 10% from the beginning of the year, still down 11.61% from its 52 week high of $672.34 set on December 31, 2021. They are under-performing the S&P 500 which is down 4.61% from the start of the year.
Thermo Fisher Scientific follows other major Healthcare sector earnings this month
Thermo Fisher Scientific's report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar